Abstract
Preoperative injection of Botulinum Toxin A (Botox) has been described as an adjunctive therapy to facilitate fascial closure of large hernia defects in abdominal wall reconstruction (AWR). The purpose of this study was to evaluate the impact of Botox injections on fascial closure and overall outcomes to further validate its role in AWR. A prospectively maintained database was retrospectively reviewed to identify all patients undergoing AWR at our institution between January 2014 and March 2022. Patients who did and did not receive preoperative Botox injections were analyzed and compared. A total of 426 patients were included (Botox 76, NBotox 350). The Botox group had significantly larger hernia defects (90 cm2 vs 9 cm2, p < 0.01) and a higher rate of component separations performed (60.5% vs 14.4%, p < 0.01). Despite this large difference in hernia defect size, primary fascial closure rates were similar between the groups (p = 0.49). Notably, the Botox group had higher rates of surgical-site infections (SSIs)/surgical-site occurrences (SSOs) (p < 0.01). Following propensity score matching to control for multiple patient factors including age, sex, diabetes, chronic obstructive pulmonary disease (COPD), and hernia size, the Botox group still had a higher rate of component separations (50% vs 26.3%, p = 0.03) and higher incidence of SSIs/SSOs (39.5% vs 13.5%, p = 0.01). Multimodal therapy with Botox injections and component separations can help achieve fascial closure of large defects during AWR. However, adding these combined therapies may increase the occurrence of postoperative SSIs/SSOs.
Similar content being viewed by others
Data availability
The datasets used for the current study may be available from the corresponding author on reasonable request.
References
Deerenberg EB et al (2021) Image-guided botulinum toxin injection in the lateral abdominal wall prior to abdominal wall reconstruction surgery: review of techniques and results. Skeletal Radiol 50(1):1–7
Deerenberg EB et al (2015) Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial. Lancet 386(10000):1254–1260
Jairam AP et al (2017) Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement versus primary suture only in midline laparotomies (PRIMA): 2-year follow-up of a multicentre, double-blind, randomised controlled trial. Lancet 390(10094):567–576
Kingsnorth A, LeBlanc K (2003) Hernias: inguinal and incisional. Lancet 362(9395):1561–1571
Hope, W.W. and F. Tuma, Incisional Hernia, in StatPearls. 2022: Treasure Island (FL).
Hope, W.W., W. Abdul, and R. Winters, abdominal wall reconstruction, In: StatPearls. 2022: Treasure Island (FL).
Singhal V et al (2012) Ventral hernia repair: outcomes change with long-term follow-up. JSLS 16(3):373–379
Soltanizadeh S, Helgstrand F, Jorgensen LN (2017) Botulinum Toxin A as an adjunct to abdominal wall reconstruction for incisional hernia. Plast Reconstr Surg Glob Open 5(6):e1358
Booth JH et al (2013) Primary fascial closure with mesh reinforcement is superior to bridged mesh repair for abdominal wall reconstruction. J Am Coll Surg 217(6):999–1009
Holihan JL et al (2016) Component separation vs. bridged repair for large ventral hernias: a multi-institutional risk-adjusted comparison, systematic review, and meta-analysis. Surg Infect (Larchmt) 17(1):17–26
Maloney SR et al (2019) Twelve years of component separation technique in abdominal wall reconstruction. Surgery 166(4):435–444
Eriksson A, Rosenberg J, Bisgaard T (2014) Surgical treatment for giant incisional hernia: a qualitative systematic review. Hernia 18(1):31–38
Dressler D (2012) Clinical applications of botulinum toxin. Curr Opin Microbiol 15(3):325–336
Ibarra-Hurtado TR et al (2009) Use of botulinum toxin type a before abdominal wall hernia reconstruction. World J Surg 33(12):2553–2556
Weissler JM et al (2017) Chemical component separation: a systematic review and meta-analysis of botulinum toxin for management of ventral hernia. J Plast Surg Hand Surg 51(5):366–374
Zendejas B et al (2013) Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs. World J Surg 37(12):2830–2837
Zielinski MD et al (2016) Botulinum toxin A-induced paralysis of the lateral abdominal wall after damage-control laparotomy: a multi-institutional, prospective, randomized, placebo-controlled pilot study. J Trauma Acute Care Surg 80(2):237–242
Wegdam JA et al (2021) Prehabilitation of complex ventral hernia patients with Botulinum: a systematic review of the quantifiable effects of Botulinum. Hernia 25(6):1427–1442
Farooque F et al (2016) Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair. ANZ J Surg 86(1–2):79–83
Ibarra-Hurtado TR et al (2014) Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management. Hernia 18(5):647–652
Rodriguez-Acevedo O et al (2018) Preoperative botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. Surg Endosc 32(2):831–839
Cui P, Fang X (2015) Pathogenesis of infection in surgical patients. Curr Opin Crit Care 21(4):343–350
Dias ERM et al (2023) Systematic review and meta-analysis of the pre-operative application of botulinum toxin for ventral hernia repair. Hernia 27(4):807–818
Timmer AS et al (2021) A systematic review and meta-analysis of technical aspects and clinical outcomes of botulinum toxin prior to abdominal wall reconstruction. Hernia 25(6):1413–1425
Author information
Authors and Affiliations
Contributions
All authors listed above contributed to this manuscript and meet the requirements of appropriate authorship as defined by the International Committee of Medical Journal Editors (ICMJE).
Corresponding author
Ethics declarations
Research involving human participants and/or animals
Not applicable for this study.
Informed consent
Not applicable for this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fair, L., Leeds, S.G., Bokhari, S.H. et al. Achieving fascial closure with preoperative botulinum toxin injections in abdominal wall reconstruction: outcomes from a high-volume center. Updates Surg (2024). https://doi.org/10.1007/s13304-024-01802-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13304-024-01802-w